Matthew J Crowley1, Rob Holleman2, Mandi L Klamerus2, Hayden B Bosworth3, David Edelman3, Michele Heisler2. 1. Center for Health Services Research in Primary Care, Durham VA Medical Center, Durham, NC, USA matthew.crowley@dm.duke.edu. 2. Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA. 3. Center for Health Services Research in Primary Care, Durham VA Medical Center, Durham, NC, USA.
Abstract
OBJECTIVES: Patients with persistent poorly controlled diabetes mellitus (PPDM), defined as an uninterrupted hemoglobin A1c >8.0% for ≥1 year despite standard care, are at high risk for complications. Additional research to define patient factors associated with PPDM could suggest barriers to improvement in this group and inform the development of targeted strategies to address these patients' resistant diabetes. METHODS: We analyzed patients with type 2 diabetes from a multi-site randomized trial. We characterized patients with PPDM relative to other patients using detailed survey data and multivariable modeling. RESULTS: Of 963 patients, 118 (12%) had PPDM, 265 (28%) were intermittently poorly controlled, and 580 (60%) were well-controlled. Patients with PPDM had younger age, earlier diabetes diagnosis, insulin use, higher antihypertensive burden, higher low-density lipoprotein cholesterol, and lower statin use relative to well-controlled patients. Among patients with objective adherence data (Veterans Affairs patients), a larger oral diabetes medication refill gap was associated with PPDM. DISCUSSION: Strategies are needed to target-specific barriers to improvement among patients whose diabetes is resistant to standard diabetes care. Our data suggest that strategies for targeting PPDM should accommodate younger patients' lifestyles, include medication management for insulin titration and comorbid disease conditions, and address barriers to self-management adherence.
OBJECTIVES:Patients with persistent poorly controlled diabetes mellitus (PPDM), defined as an uninterrupted hemoglobin A1c >8.0% for ≥1 year despite standard care, are at high risk for complications. Additional research to define patient factors associated with PPDM could suggest barriers to improvement in this group and inform the development of targeted strategies to address these patients' resistant diabetes. METHODS: We analyzed patients with type 2 diabetes from a multi-site randomized trial. We characterized patients with PPDM relative to other patients using detailed survey data and multivariable modeling. RESULTS: Of 963 patients, 118 (12%) had PPDM, 265 (28%) were intermittently poorly controlled, and 580 (60%) were well-controlled. Patients with PPDM had younger age, earlier diabetes diagnosis, insulin use, higher antihypertensive burden, higher low-density lipoprotein cholesterol, and lower statin use relative to well-controlled patients. Among patients with objective adherence data (Veterans Affairs patients), a larger oral diabetes medication refill gap was associated with PPDM. DISCUSSION: Strategies are needed to target-specific barriers to improvement among patients whose diabetes is resistant to standard diabetes care. Our data suggest that strategies for targeting PPDM should accommodate younger patients' lifestyles, include medication management for insulin titration and comorbid disease conditions, and address barriers to self-management adherence.
Authors: Imad M El-Kebbi; Curtiss B Cook; David C Ziemer; Christopher D Miller; Daniel L Gallina; Lawrence S Phillips Journal: Arch Intern Med Date: 2003-01-13
Authors: Woolton Lee; Jennifer T Lloyd; Katherine Giuriceo; Timothy Day; William Shrank; Rahul Rajkumar Journal: Health Serv Res Date: 2020-07-27 Impact factor: 3.402
Authors: Tessa M Napoles; Nancy J Burke; Janet K Shim; Elizabeth Davis; David Moskowitz; Irene H Yen Journal: J Urban Health Date: 2017-12 Impact factor: 3.671
Authors: Satyajeet Roy; Anthony Sherman; Mary Joan Monari-Sparks; Olga Schweiker; Navjot Jain; Etty Sims; Michelle Breda; Gita P Byraiah; Ryan George Belecanech; Michael Domenic Coletta; Cristian Javier Barrios; Krystal Hunter; John P Gaughan Journal: N Am J Med Sci Date: 2016-01
Authors: Michele Heisler; Jennifer Burgess; Jeffrey Cass; John F Chardos; Alexander B Guirguis; Sean M Jeffery; Lorrie A Strohecker; Adam S Tremblay; Wen-Chih Wu; Donna M Zulman Journal: Trials Date: 2017-05-26 Impact factor: 2.279
Authors: Sara M Andrews; Nina R Sperber; Jennifer M Gierisch; Susanne Danus; Stephanie L Macy; Hayden B Bosworth; David Edelman; Matthew J Crowley Journal: Patient Prefer Adherence Date: 2017-03-03 Impact factor: 2.711
Authors: Nathalie Jeandidier; Lucy Chaillous; Sylvia Franc; Pierre-Yves Benhamou; Pauline Schaepelynck; Hélène Hanaire; Bogdan Catargi; Anne Farret; Pierre Fontaine; Bruno Guerci; Yves Reznik; Alfred Penfornis; Sophie Borot; Pierre Serusclat; Yacine Kherbachi; Geneviève D'Orsay; Bruno Detournay; Pierre Simon; Guillaume Charpentier Journal: JMIR Res Protoc Date: 2018-04-19
Authors: Saria Hassan; Cherlie Magny-Normilus; Deron Galusha; Oswald P Adams; Rohan G Maharaj; Cruz M Nazario; Maxine Nunez; Marcella Nunez-Smith Journal: Prim Care Diabetes Date: 2021-07-10 Impact factor: 2.459